Multicomponent Synthesis of Pyrano (3, 2-c) Quinolone Fused Spirochromenes

References

• A. Strecker, “Ueber Die künstlicheBildung Der Milchsäure Und Einenneuen, demGlycocollhomologenKörper, Leibigs,” Justus Liebigs Annalen Der Chemie 7 (1850): 27–45.
   Google Scholar
• J. Zhu and H. Bienayme, Multicomponent Reactions, eds. J. Zhu, and H. Bieayme (Wienheim, Germany: Wiley – VCH, 2005).
   Google Scholar
• M. S. Singh, and S. Chowdhury, “Recent Developments in Solvent-Free Multicomponent Reactions: A Perfect Synergy for Eco-Compatible Organic Synthesis,” RSC Advances 2, no. 11 (2012): 4547–92.
   Web of Science ®Google Scholar
• B. H. Rotstein, S. Zaretsky, V. Rai, and A. K. Yudin, “Small Heterocycles in Multicomponent Reactions,” Chemical Reviews 114, no. 16 (2014): 8323–59.
   PubMed Web of Science ®Google Scholar
• E. Ruijter, and R. V. Orru, “Multicomponent Reactions - Opportunities for the Pharmaceutical Industry,” Drug Discovery Today:Technologies 10 (2013): 15–20.
   PubMedGoogle Scholar
• J. E. Biggs-Houck, A. Younai, and J. T. Shaw, “Recent Advances in Multicomponent Reactions for Diversity-Oriented Synthesis,” Current Opinion in Chemical Biology 14, no. 3 (2010): 371–82.
   PubMed Web of Science ®Google Scholar
• S. Manohar, U. C. Rajesh, S. I. Khan, B. L. Tekwani, and D. S. Rawat, “Novel 4-Aminoquinoline-Pyrimidine Based Hybrids with Improved in Vitro and in Vivo Antimalarial Activity,” ACS Medicinal Chemistry Letters 3, no. 7 (2012): 555–9.
   PubMed Web of Science ®Google Scholar
• C. Viegas Jr., A. Danuello, V. daSilva Bolzani, V. E. J. Barreiro, and C. A. M. Fraga, “Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes,” Current Medicinal Chemistry 14 (2007): 1829–52.
   PubMed Web of Science ®Google Scholar
• I. A. Ibarra, A. Islas-Jacome, and E. González-Zamora, “Synthesis of Polyheterocycles via Multicomponent Reactions,” Organic & Biomolecular Chemistry 16, no. 9 (2018): 1402–18.
   PubMed Web of Science ®Google Scholar
• N. Sharma, D. Mohanakrishnan, A. Shard, A. Sharma, Saima, A. K. Sinha, and D. Sahal, “Stilbene–Chalcone Hybrids: design, Synthesis, and Evaluation as a New Class of Antimalarial Scaffolds That Trigger Cell Death through Stage Specific Apoptosis,” Journal of Medicinal Chemistry 55 (2012): 297–11.
   PubMed Web of Science ®Google Scholar
• F. W. Muregi, and A. Ishih, “Next-Generation Antimalarial Drugs: hybrid Molecules as a New Strategy in Drug Design,” Drug Development Research 71, no. 1 (2010): 20–32.
   PubMed Web of Science ®Google Scholar
• M. Decker, “Hybrid Molecules Incorporating Natural Products: applications in Cancer Therapy, Neurodegenerative Disorders and beyond,” Current Medicinal Chemistry 18, no. 10 (2011): 1464–75.
   PubMed Web of Science ®Google Scholar
• D. Sunil, and P. R. Kamath, “Multi-Target Directed Indole Based Hybrid Molecules in Cancer Therapy : An Up-To-Date Evidence-Based Review,” Current Topics in Medicinal Chemistry 17, no. 9 (2017): 959–85.
   PubMed Web of Science ®Google Scholar
• G. S. Singh, and Z. Y. Desta, “Isatins as Privileged Molecules in Design and Synthesis of Spiro-Fused Cyclic Frameworks,” Chemical Reviews 112, no. 11 (2012): 6104–55.
   PubMed Web of Science ®Google Scholar
• A. H. Abdel-Rahman, E. M. Keshk, M. A. Hanna, and S. M. El-Bady, “Synthesis and Evaluation of Some New Spiro Indoline-Based Heterocycles as Potentially Active Antimicrobial Agents,” Bioorganic & Medicinal Chemistry 12, no. 9 (2004): 2483–8.
   PubMed Web of Science ®Google Scholar
• A. Dandia, D. Saini, S. Bhaskaran, and D. K. Saini, “Ultrasound Promoted Green Synthesis of Spiro [Pyrano(2, 3- c) Pyrazoles] as Antioxidant Agents,” Medicinal Chemistry Research 23, no. 2 (2014): 725–34.
   Web of Science ®Google Scholar
• J. Liu, Y. Song, X. Zhang, X. Liang, Y. Wu, Y. Wang, and X. Jiang, “Spirooxindoles, a Potential Class of anti-Inflammatory Agents,” Inflammation and Cell Signaling 1 (2014): 374–8.
   Google Scholar
• V. V. Vintonyak, K. Warburg, H. Kruse, S. Grimme, K. Hubel, D. Rauh, and H. Waldmann, “Identification of Thiazolidinones Spiro-Fused to Indolin-2-Ones as Potent and Selective Inhibitors of the Mycobacterium tuberculosis Protein Tyrosine Phosphatase B,” Angewandte Chemie (International ed. in English) 49, no. 34 (2010): 5902–5.
   PubMed Web of Science ®Google Scholar
• B. Yu, D. Q. Yu, and H. M. Liu, “Spirooxindoles: Promising Scaffolds for Anticancer Agents,” European Journal of Medicinal Chemistry 97 (2015): 673–98.
   PubMed Web of Science ®Google Scholar
• B. E. Evans, K. E. Rittle, M. G. Bock, R. M. DiPardo, R. M. Freidinger, W. L. Whitter, G. F. Lundell, D. F. Veber, P. S. Andersons andR, and S. Chang, “Rhodium(II) Acetate-Catalyzed Stereoselective Synthesis, SAR and anti-HIV Activity of Novel Oxindoles Bearing Cyclopropane Ring,” European Journal of Medicinal Chemistry 46 (2011): 1181–8.
   PubMed Web of Science ®Google Scholar
• Tetyana L. Pavlovska, Ruslan Gr Redkin, Victoria V. Lipson, and Dmytro V. Atamanuk, “Molecular Diversity of Spirooxindoles. Synthesis and Biological Activity,” Molecular Diversity 20, no. 1 (2016): 299–44.
   PubMed Web of Science ®Google Scholar
• M. M. M. Santos, “Recent Advances in the Synthesis of Biologically Active Spirooxindoles,” Tetrahedron 70, no. 52 (2014): 9735–57. and references cited therein.
   Web of Science ®Google Scholar
• S. Zhu, J. Wang, Z. Xu, and J. Li, “An Efficient One-Pot Synthesis of Pyrano[3,2-c]Quinolin-2,5-Dione Derivatives Catalyzed by L-Proline,” Molecules (Basel, Switzerland) 17, no. 12 (2012): 13856–63.
   PubMed Web of Science ®Google Scholar
• M.-J. Yao, Z. Guan, and Y.-H. He, “Simple, Catalyst-Free, One-Pot Procedure for the Synthesis of 2-Amino-3-Cyano-1,4,5,6-Tetrahydropyrano[3,2-c]Quinolin-5-One Derivatives,” Synthetic Communications 43, no. 15 (2013): 2073–8.
   Web of Science ®Google Scholar
• I. V. Magedov, M. Manpadi, M. A. Ogasawara, A. S. Dhawan, S. Rogelj, S. Van Slambrouck, W. F. A. Steelant, N. M. Evdokimov, P. Y. Uglinskii, E. M. Elias, et al. “Structural Simplification of Bioactive Natural Products with Multicomponent Synthesis. 2. Antiproliferative and Antitubulin Activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones,” Journal of Medicinal Chemistry 51, no. 8 (2008): 2561–70.
   PubMed Web of Science ®Google Scholar
• K. S. Atwal, J. R. McCullough, A. Hedberg, M. L. Conder, S. Z. Ahmed, G. Cucinotta, and D. E. Normandin, “The Discovery of a Novel Calcium Channel Blocker Related to the Structure of Potassium Channel Opener Cromakalim,” Bioorganic & Medicinal Chemistry Letters 2, no. 12 (1992): 1475–8.
   Web of Science ®Google Scholar
• S. T. Hilton, T. C. T. Ho, G. Pljevaljcic, and K. Jones, “A New Route to Spirooxindoles,” Organic Letters 2, no. 17 (2000): 2639–41.
   PubMed Web of Science ®Google Scholar
• A. A. Aly, E. M. El-Sheref, A.-F E. Mourad, A. B. Brown, S. Brase, M. E. M. Bakheet, and M. Nieger, “Synthesis of Spiro[Indoline-3,4′-Pyrano[3,2-c]Quinolone]-3′-Carbonitriles,” Monatshefte Für Chemie - Chemical Monthly 149, no. 3 (2018): 635–44. 149,
   Google Scholar
• M. A. Nasseri, and S. M. Sadeghzadeh, “A Highly Active FeNi3-SiO2 Magnetic Nanoparticles Catalyst for the Preparation of 4H-Benzo[b]Pyrans and Spirooxindoles under Mild Conditions,” Journal of the Iranian Chemical Society 10, no. 5 (2013): 1047–56.
   Web of Science ®Google Scholar
• S. S. Khot, P. V. Anbhule, U. V. Desai, and P. P. Wadgaonkar, “Tris-Hydroxymethyl-Aminomethane (THAM) as an Efficient Organocatalyst in Diversity Oriented and Environmentally Benign Synthesis of Spirochromenes,” Comptes Rendus Chimie 21, no. 9 (2018): 814–21.
   Web of Science ®Google Scholar
• L. Han, X. Hu, and Z. Zhou, “Diammonium Hydrogen Phosphate as a Recyclable Catalyst for the Rapid and Green Synthesis of 2-Amino-1,4,5,6-Tetrahydropyrano[3,2-c]-Quinolin-5-One Derivatives,” Polycyclic Aromatic Compounds 37, no. 1 (2017): 73–80.
   Web of Science ®Google Scholar
• R. L. L. de Compadre, R. A. Pearlstein, A. J. Hopfinger, and J. K. Seyde, “A Quantitative Structure-Activity Relationship Analysis of Some 4-Aminodiphenyl Sulfone Antibacterial Agents Using Linear Free Energy and Molecular Modeling Methods,” Journal of Medicinal Chemistry 30, no. 5 (1987): 900–6.
   PubMed Web of Science ®Google Scholar
• Z. Y. Sun, E. Botros, A. D. Su, Y. Kim, E. Wang, N. Z. Baturay, and C. H. Kwon, “ Sulfoxide-Containing Aromatic Nitrogen Mustards as Hypoxia-Directed Bioreductive Cytotoxins ,” Journal of Medicinal Chemistry 43, no. 22 (2000): 4160–8.
   PubMed Web of Science ®Google Scholar
• M. Artico, R. Silvestri, E. Pagnozzi, B. Bruno, E. Novellino, G. Greco, S. Massa, A. Ettorre, A. G. Loi, F. Scintu, et al. “Structure-Based Design, Synthesis, and Biological Evaluation of Novel Pyrrolyl Aryl Sulfones: HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors Active at Nanomolar Concentrations,” Journal of Medicinal Chemistry 43, no. 9 (2000): 1886–91.
   PubMed Web of Science ®Google Scholar
• M. Teall, P. Oakley, T. Harrison, D. Shaw, E. Kay, J. Elliott, U. Gerhard, J. L. Castro, M. Shearman, R. G. Ball, et al. “Aryl Sulfones: A New Class of Gamma-Secretase Inhibitors,” Bioorganic & Medicinal Chemistry Letters 15, no. 10 (2005): 2685–92.
   PubMed Web of Science ®Google Scholar
• D. C. Meadows, T. Sanchez, N. Neamati, T. W. North, and J. Gervay-Hague, “Ring Substituent Effects on Biological Activity of Vinyl Sulfones as Inhibitors of HIV-1,” Bioorganic & Medicinal Chemistry 15, no. 2 (2007): 1127–37.
   PubMed Web of Science ®Google Scholar
• S. S. Jin, H. Wang, and H. Y. Guo, “Ionic Liquid Catalyzed One-Pot Synthesis of Novel Spiro-2-Amino-3-Phenylsulfonyl-4H-Pyran Derivatives,” Tetrahedron Letters 54, no. 19 (2013): 2353–6.
   Web of Science ®Google Scholar
• A. S. Al-Bogami, “One-Pot, Three Component Synthesis of Novel Pyrano [3 2-c] Coumarins Containing Sulfone Moiety Utilizing Ultrasonic Irradiation as Eco-Friendly Energy Source,” Research on Chemical Intermediates 41, no. 1 (2015): 93–104.
   Web of Science ®Google Scholar
• K. S. Pandit, R. V. Kupwade, P. V. Chavan, U. V. Desai, P. P. Wadgaonkar, and K. M. Kodam, “Problem Solving and Environmentally Benign Approach toward Diversity Oriented Synthesis of Novel 2-Amino-3-Phenyl (or Alkyl) Sulfonyl-4H-Chromenes at Ambient Temperature,” ACS Sustainable Chemistry & Engineering 4, no. 6 (2016): 3450–64.
   Web of Science ®Google Scholar
• K. S. Pandit, P. V. Chavan, M. A. Kulkarni, U. V. Desai, and P. P. Wadgaonkar, “Tris-Hydroxymethylaminomethane (THAM): a Novel Organocatalyst for a Environmentally Benign Synthesis of Medicinally Important Tetrahydrobenzo[b]Pyrans and Pyran-Annulated Heterocycles,” New Journal of Chemistry 39, no. 6 (2015): 4452–68.
   Web of Science ®Google Scholar
• M. A. Kulkarni, V. R. Pandurangi, U. V. Desai, and P. P. Wadgaonkar, “A Practical and Highly Efficient Protocol for Multicomponent Synthesis of β-Phosphonomalononitriles and 2-Amino-4H-Chromen-4-yl-Phosphonates Using Diethylamine as a Novel Organocatalyst,” Comptes Rendus Chimie 15, no. 9 (2012): 745–52.
   Web of Science ®Google Scholar
• M. A. Kulkarni, K. S. Pandit, U. V. Desai, U. P. Lad, and P. P. Wadgaonkar, “Diethylamine: A Smart Organocatalyst in Eco-Safe and Diastereoselective Synthesis of Medicinally Privileged 2-Amino-4H-Chromenes at Ambient Temperature,” Comptes Rendus Chimie 16, no. 8 (2013): 689–95.
   Web of Science ®Google Scholar
• J. J. Li, Name Reactions for Carbocyclic Ring Formation (Hoboken, New Jersey: John Wiley & Sons, 2010), ISBN: 9780470085066.
   Google Scholar